First Midwest Bank Trust Division’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $5.28M | Buy |
89,409
+4,775
| +6% | +$237K | 0.68% | 33 |
|
|
2021
Q3 | $3.64M | Sell |
84,634
-10,166
| -11% | -$450K | 0.52% | 43 |
|
|
2021
Q2 | $3.71M | Sell |
94,800
-6,717
| -7% | -$261K | 0.5% | 48 |
|
|
2021
Q1 | $3.68M | Buy |
101,517
+8,169
| +9% | +$290K | 0.51% | 47 |
|
|
2020
Q4 | $3.44M | Buy |
93,348
+3,562
| +4% | +$131K | 0.5% | 52 |
|
|
2020
Q3 | $3.13M | Buy |
89,786
+400
| +0.4% | +$14K | 0.49% | 49 |
|
|
2020
Q2 | $2.77M | Sell |
89,386
-2,031
| -2% | -$69K | 0.45% | 55 |
|
|
2020
Q1 | $2.83M | Buy |
91,417
+14,626
| +19% | +$498K | 0.52% | 41 |
|
|
2019
Q4 | $2.85M | Buy |
76,791
+553
| +0.7% | +$19.7K | 0.39% | 64 |
|
|
2019
Q3 | $2.6M | Sell |
76,238
-18,913
| -20% | -$688K | 0.37% | 64 |
|
|
2019
Q2 | $3.91M | Sell |
95,151
-2,168
| -2% | -$86.1K | 0.56% | 47 |
|
|
2019
Q1 | $3.92M | Sell |
97,319
-5,660
| -5% | -$227K | 0.53% | 46 |
|
|
2018
Q4 | $4.26M | Buy |
102,979
+8,224
| +9% | +$341K | 0.64% | 35 |
|
|
2018
Q3 | $3.96M | Sell |
94,755
-6,894
| -7% | -$265K | 0.53% | 44 |
|
|
2018
Q2 | $3.5M | Sell |
101,649
-2,343
| -2% | -$80.1K | 0.5% | 43 |
|
|
2018
Q1 | $3.5M | Sell |
103,992
-6,536
| -6% | -$225K | 0.48% | 49 |
|
|
2017
Q4 | $3.8M | Sell |
110,528
-2,672
| -2% | -$91.1K | 0.47% | 47 |
|
|
2017
Q3 | $3.83M | Buy |
113,200
+3,305
| +3% | +$106K | 0.47% | 52 |
|
|
2017
Q2 | $3.5M | Buy |
109,895
+307
| +0.3% | +$9.68K | 0.43% | 54 |
|
|
2017
Q1 | $3.56M | Sell |
109,588
-13,631
| -11% | -$430K | 0.43% | 50 |
|
|
2016
Q4 | $3.8M | Sell |
123,219
-684
| -0.6% | -$20.9K | 0.46% | 47 |
|
|
2016
Q3 | $3.98M | Buy |
123,903
+6,107
| +5% | +$204K | 0.5% | 48 |
|
|
2016
Q2 | $3.94M | Buy |
117,796
+2,200
| +2% | +$70.2K | 0.49% | 53 |
|
|
2016
Q1 | $3.25M | Buy |
115,596
+8,200
| +8% | +$234K | 0.43% | 65 |
|
|
2015
Q4 | $3.29M | Sell |
107,396
-4,568
| -4% | -$144K | 0.55% | 55 |
|
|
2015
Q3 | $3.34M | Buy |
111,964
+9,556
| +9% | +$306K | 0.58% | 39 |
|
|
2015
Q2 | $3.26M | Sell |
102,408
-47,254
| -32% | -$1.54M | 0.52% | 44 |
|
|
2015
Q1 | $4.94M | Sell |
149,662
-11,633
| -7% | -$370K | 0.76% | 26 |
|
|
2014
Q4 | $4.77M | Buy |
161,295
+8,837
| +6% | +$253K | 0.74% | 27 |
|
|
2014
Q3 | $4.28M | Sell |
152,458
-6,634
| -4% | -$186K | 0.69% | 29 |
|
|
2014
Q2 | $4.48M | Buy |
159,092
+64,907
| +69% | +$1.85M | 0.7% | 27 |
|
|
2014
Q1 | $2.87M | Buy |
94,185
+3,282
| +4% | +$97.9K | 0.47% | 50 |
|
|
2013
Q4 | $2.64M | Buy |
90,903
+1,266
| +1% | +$36.8K | 0.46% | 57 |
|
|
2013
Q3 | $2.44M | Sell |
89,637
-2,252
| -2% | -$61.3K | 0.48% | 53 |
|
|
2013
Q2 | $2.44M | Buy |
+91,889
| New | +$2.54M | 0.49% | 53 |
|
Other funds holding PFE
First Midwest Bank Trust Division's PFE Position: Q4 2021 in Review
First Midwest Bank Trust Division increased its Pfizer (PFE) stake by 5.6% in Q4 2021, buying an estimated $237K and bringing the position to 89,409 shares worth $5.28M. The position accounts for 0.68% of the portfolio, ranked #33.
First Midwest Bank Trust Division first reported a position in PFE in Q2 2013 and has held it in 35 quarters since. 3,262 funds tracked by Wall St. Rank hold PFE as of Q4 2021.
- First Midwest Bank Trust Division held 89,409 shares of Pfizer worth $5.28M as of Q4 2021.
- First Midwest Bank Trust Division bought 4,775 Pfizer shares in Q4 2021, an estimated $237K.
- Pfizer made up 0.68% of First Midwest Bank Trust Division's portfolio in Q4 2021, its #33 holding.
- First Midwest Bank Trust Division first reported a position in Pfizer in Q2 2013 and has held it in 35 quarters since.
- 3,262 funds tracked by Wall St. Rank held Pfizer as of Q4 2021.
Based on First Midwest Bank Trust Division's 13F filing for Q4 2021, filed 18 Jan 2022.